US FDA makes recommendations for influenza vaccines

After canceling meeting of independent advisers, FDA issues 2025-26 flu vaccine recommendations
The US Food and Drug Administration on Thursday issued recommendations for the composition of influenza shots for the upcoming respiratory virus season, but without input from its independent vaccine advisers.
US FDA makes recommendations for influenza vaccines to manufacturers
The U.S. Food and Drug Administration on Thursday made recommendations to vaccine manufacturers for the virus strains to be used in influenza vaccines for the 2025-2026 flu season in the United States.
FDA sets flu shot recommendations without input of outside advisers
The agency formulated its advice to manufacturers after coordinating with the CDC and Defense Department. An advisory meeting that's typically held was canceled last month.
FDA issues flu vaccine recommendations for 2025-26 season
The Food and Drug Administration has issued recommendations for the composition of influenza shots for the upcoming respiratory virus season, but without input from its independent vaccine advisers.
Government panel steps in after FDA cancels advisory meeting on flu shot recommendations
After the FDA canceled a key advisory meeting, government doctors stepped in to propose a trivalent flu vaccine for the upcoming 2025-26 season.
FDA Makes Flu Vaccine Recommendations Without Convening Advisors
The recommendations were made in a closed session with representatives from CBER, the CDC and Department of Defense.
FDA issues flu vaccine recommendations: 5 respiratory updates
Here are four more updates: Influenza activity remained elevated but has been declining for four consecutive weeks. Flu-related emergency department visits remain moderate, and test positivity is at 16.1%.
Trump’s pick to lead FDA tells senators he’d look into food, abortion pill, vaccine advisers
President Donald Trump’s pick to lead the US Food and Drug Administration told senators in a tense confirmation hearing ...
Dr. Marty Makary advances out of key committee in bid for FDA confirmation
President Donald Trump's nominee to lead the Food and Drug Administration (FDA), Dr. Marty Makary, passed a key committee vote on Thursday morning.
MRNA vaccines now face attacks from some in the GOP
The Florida surgeon general in January called for a halt in the use of covid mRNA vaccines. And in Texas, Attorney General ...